Developer docs
API playgroundTry for free, no card

Search company profiles

Statnews

Full company profile

uuid0006hn5

Namestring
Statnews
Legal namestring
STAT
Websiteurl
statnews.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

STAT (published as STAT News) is a Boston-based, for-profit health, medicine and life sciences news organization founded in 2015 and operating under the Boston Globe Media umbrella. It produces original reporting, investigations and series across biotech, pharma, health tech, health insurance, hospitals, medical devices, health policy (FDA, NIH), science (CRISPR, gene therapy, neuroscience) and public health. Coverage is produced by specialist correspondents and reporters, including a Washington bureau (HHS and FDA reporters), a Europe correspondent and reporters covering biotech startups and venture capital. STAT sells primarily to three reader groups: life sciences and biopharma business professionals (biotech, pharma, health tech, investors), health policy and government stakeholders, and general readers interested in health and science, plus institutional buyers (hospitals, universities, libraries, life sciences companies). The company states it remains editorially independent and that its financial supporters — including Bloomberg Philanthropies, The Boston Foundation, The Commonwealth Fund, Dana Foundation, Greenwall Foundation, the Knight Science Journalism Program at MIT, NIHCM Foundation, Rise Together and the Robert Wood Johnson Foundation — are not involved in editorial decisions.\n\nThe core product is the STAT+ subscription, a tiered offering that gates in-depth analysis, exclusive reporting, newsletters, premium events, news alerts, podcasts and research reports, delivered on a WordPress-based publishing platform with paywall, account, billing and alert management, a mobile app, a reports storefront, an events platform, and analytics-driven personalization of the subscriber experience. Priced at $39/month, $399/year (advertised as 15% below twelve monthly payments), and a promotional starter tier of $30 for three months before reverting to $399/year, with cancel-anytime terms and discounts for students, educators and health care workers; group subscriptions run $300 per user per year self-serve for 2-10 users with request-a-quote contracts for 11+ users at savings starting at 25%. Four editorially maintained databases form the paid "Tools & Trackers" line: the CRISPR Tracker, the Breakthrough Device Tracker (described as an authoritative database of FDA fast-tracked devices), the Generative AI Tracker and the Obesity Drug Tracker, which covers dozens of weight-loss drugs in development.\n\nRevenue comes from five streams: recurring individual and group STAT+ subscriptions, one-off paid research reports (for example, "Chaotic and politicized: Inside the FDA under Trump" at $49, and the 2025 ranking of biotech's top venture capital firms) through reports.statnews.com, advertising and branded content via the in-house STAT Brand Studio, third-party content licensing (Muck Rack became the first communications platform to license STAT content, announced May 19, 2026) and reprints through Pars International, and a freemium funnel of free newsletters (Morning Rounds, The Readout, Pharmalittle, Pharmalot, D.C. Diagnosis, Readout LOUD, Lab Dish), podcasts (First Opinion, Color Code) and a weekday mini crossword. A dedicated senior vice president for growth & subscriptions and a chief operating officer sit alongside co-founder and executive editor Rick Berke. No revenue, subscriber count, funding history or cap-table data is disclosed in the supplied material.

Short descriptiontext

STAT (STAT News) is a Boston-based health, medicine and life sciences news organization founded in 2015, owned by Boston Globe Media. It publishes original reporting and sells a paid STAT+ subscription, proprietary research trackers, paid reports, events and branded content to life sciences professionals, policy stakeholders, institutional buyers and general readers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
health and medicine journalism, life sciences news publishing, subscription news content, biotech and pharma reporting, digital media subscription
Industry3 codes
PRIMARYMPAJADAK
Data Journalism & News Intelligence Publishers (Indexes, Election/Market Data)
Media, Entertainment & Sports/Publishing (Books, News, Magazines)/News Publishing (Newspapers, Digital Newsrooms, Wire Services)
SECONDARYMPAJAAAL
Health, Wellness & Fitness Trade Publishing
SECONDARYMPAJAEAD
Health, Fitness & Wellness Magazines
Media, Entertainment & Sports/Publishing (Books, News, Magazines)/Magazine Publishing (Consumer & B2B/Trade Magazines)
NAICS code3 codes
  • Periodical Publishers513120
  • Newspaper, Periodical, Book, and Directory Publishers5131
  • Directory and Mailing List Publishers51314
SIC code1 code
  • Newspapers: Publishing Or Publishing & Printing2711
Product category
Digital Health and Life Sciences Media
Social media profiles3 records
GTM motion5 records

Each record includes

Type, Description, Source

Revenue model6 records
1STAT+ individual subscriptions
TypeSubscription Recurring
Description

Paid access to exclusive reporting, analysis, newsletters, premium events and alerts for individual readers; monthly and annual billing with a promotional starter tier and cancel-anytime terms. Annual plan priced at $399 versus $468 for twelve monthly payments (15% saving).

statnews.com
2STAT+ group subscriptions
TypeSubscription Recurring
Description

Organization-wide access for teams: self-serve annual seats at $300 per user for 2-10 users and custom-priced contracts for 11+ users with savings starting at 25%, typically sold to hospitals, universities, libraries and life sciences companies.

statnews.com
3Paid research reports (STAT Reports)
TypeTransaction Fee
Description

One-off sales of long-form data-and-analysis reports through the reports.statnews.com storefront, e.g. 'Chaotic and politicized: Inside the FDA under Trump' at $49, alongside rankings such as the 2025 edition ranking biotech's top venture capital firms.

statnews.com
4Advertising and branded content
TypeAdvertising
Description

Sponsored content and advertising, including a dedicated in-house brand studio (STAT Brand Studio) that creates branded assets for sponsors, supported by an 'Advertise With Us' offering.

statnews.com
5Content licensing
TypeLicensing Royalties
Description

Licensing of STAT journalism to third-party communications platforms; Muck Rack became the first communications platform to license STAT content.

salestechstar.com
6Free newsletters and podcasts (acquisition funnel)
TypeFreemium
Description

Free daily and weekly newsletters (Morning Rounds, The Readout, Readout LOUD, Pharmalittle, Pharmalot, D.C. Diagnosis, Lab Dish) and free podcasts that build the audience funnel into paid STAT+ subscriptions rather than direct revenue.

statnews.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details6 tiers
1Individual monthly STAT+ plan
ModelSubscriptionBilling cadenceMonthly
Notes

$39 per month, totaling $468 per year; cancel anytime.

statnews.com
2Starter promotional annual plan
ModelSubscriptionBilling cadenceAnnual
Notes

$30 for 3 months, then $399 per year.

statnews.com
3Individual annual STAT+ plan
ModelSubscriptionBilling cadenceAnnual
Notes

$399 per year, advertised as saving 15%.

statnews.com
4Group subscription, 2-10 users
ModelPer seatBilling cadenceAnnual
Notes

$300 annually per user, self-serve purchase.

statnews.com
5Group subscription, 11+ users
ModelPer seatBilling cadenceAnnual
Notes

Custom pricing via request-a-quote; savings start at 25%.

statnews.com
6Individual paid research report
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

'Chaotic and politicized: Inside the FDA under Trump' report priced at $49 in the reports.statnews.com storefront.

statnews.com
GTM typeB2B and B2C
B2B and B2C
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Brand1 of 16 records shown
1STAT+
Description

STAT's paid subscription offering for in-depth analysis, newsletters, premium events and news alerts, sold as monthly ($39), annual ($399) and group plans.

statnews.com
+15 more records
Core offering1 text field

STAT (STAT News) is a Boston-based news organization founded in 2015 and published by Boston Globe Media that produces journalism about health, medicine and the life sciences, including daily news, investigative series, policy coverage, newsletters, podcasts, video and paid research reports. Its core commercial offering is the "STAT+" paid subscription ($39/month or $399/year for individuals; $300 per user annually for 2-10 user group seats with custom pricing for 11+ users), which unlocks exclusive reporting, in-depth analysis, subscriber-only newsletters, premium events, news alerts and research trackers. Monetization is supplemented by advertising and an in-house branded-content studio (STAT Brand Studio), one-off paid research reports sold through reports.statnews.com (e.g., "Chaotic and politicized: Inside the FDA under Trump" at $49), in-person events such as the annual STAT Summit, and third-party content licensing (e.g., to Muck Rack).

Differentiator
Functional benefit
Problem solved
Product overview1 text field

STAT News operates a hybrid publishing model: a free, advertising-supported news and analysis platform (news, topics and coverage areas such as Biotech, Pharma, Health Tech, Policy and Science) built around the paid "STAT+" subscription, which bundles premium reporting with a set of modular add-on tools — the STAT Reports line, the "Tools & Trackers" database modules (CRISPR Tracker, Breakthrough Device Tracker, Generative AI Tracker, Obesity Drug Tracker), the newsletter suite (Morning Rounds, The Readout, Pharmalittle, Pharmalot, D.C. Diagnosis, Lab Dish, Color Code), the podcast suite (The Readout LOUD, First Opinion, Color Code, Lab Dish) and premium events such as the STAT Summit — plus engagement products (the STAT Mini crossword, the STAT App, the STAT video channel, Shop STAT), advertising/brand services through STAT Brand Studio, and a content licensing/reprints business operated with Pars International.

Product and service15 records
1STAT+
CategorySubscription product
Description

STAT's premium paid subscription tier giving individual readers access to exclusive reporting, in-depth analysis, subscriber newsletters, premium events, news alerts, podcasts and research reports; priced at $39/month or $399/year, with group subscriptions from $300 per user annually, cancel-anytime terms, and discounted plans for students, educators and health care workers.

2STAT Reports
CategoryPaid report product
Description

One-off paid research reports blending quantitative data insights with qualitative reporting on pivotal life sciences topics, sold individually through the reports.statnews.com storefront (e.g., 'Chaotic and politicized: Inside the FDA under Trump' at $49).

3CRISPR Tracker
CategoryTracker / research tool
Description

Tool and tracker that follows the latest developments in genome editing, part of STAT's 'Tools & Trackers' line of curated research databases.

4Breakthrough Device Tracker
CategoryTracker / research tool
Description

An authoritative database of the FDA's fast-tracked (breakthrough designation) medical devices, offered under the STAT+ subscription tier.

5Generative AI Tracker
CategoryTracker / research tool
Description

A guide to the health systems and companies driving adoption of generative AI in health care, offered under the STAT+ subscription tier.

6Obesity Drug Tracker
CategoryTracker / research tool
Description

Curated tracker covering the dozens of weight-loss drugs in development, helping readers follow a fast-growing market; part of STAT's Tools & Trackers line.

7STAT Newsletters
CategoryNewsletter suite
Description

Email newsletter portfolio including Morning Rounds (daily), The Readout (biotech), Pharmalittle and Pharmalot (pharma), D.C. Diagnosis (health policy, twice-weekly), Lab Dish, First Opinion and Color Code; free signups with subscriber-only upgrades that feed the STAT+ funnel.

8STAT Podcasts
CategoryAudio content product
Description

Podcast suite covering policy to practice, including The Readout LOUD (weekly biotech podcast), First Opinion Podcast (interviews with people and ideas in medicine), Color Code (racial inequities in American health care) and Lab Dish (science and bioethics).

9STAT Events
CategoryEvents and conferences
Description

Portfolio of in-person and virtual events throughout the year, including the annual 2026 STAT Summit in Boston, MA, and virtual recaps such as the AAIC Recap on Alzheimer's; subscriber events feed the STAT+ subscription funnel.

10STAT Brand Studio
CategoryAdvertising and branded content
Description

In-house brand studio (sbs.statnews.com) providing advertising and branded content opportunities to sponsors, producing custom branded assets for health and science audiences.

11STAT Content Licensing and Reprints
CategoryContent licensing and syndication
Description

Licensing and reprint service allowing other publications to republish STAT journalism, handled through Pars International; STAT content was also licensed to Muck Rack, the first communications platform to license STAT content (announced May 19, 2026).

12STAT App
CategoryMobile application
Description

Official mobile application providing access to STAT's journalism, newsletters and STAT+ content on mobile.

13STAT Mini Crossword
CategoryEngagement product
Description

Weekday mini crossword game on the site that tests readers' knowledge of health and science news and drives habitual daily engagement.

14STAT Video
CategoryVideo content product
Description

Video channel publishing status-report explainers (e.g., 'What's next for GLP-1 weight loss drugs?'), conference coverage such as BIO 2026 and interview features.

15Shop STAT
CategoryMerchandise
Description

Official STAT-branded merchandise collection fulfilled through the Boston Globe Media online storefront (store.bostonglobe.com).

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Muck Rack
Strategic tierStrategic Licensing Deal — First Of Its Kind For Stat ContentTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2026-05-01
Description

Muck Rack became the first communications platform to license STAT content, extending STAT's journalism into communications/PR tooling and platforms. The announcement positions STAT content as licensable alongside other premium communications content.

salestechstar.com
2Pars International
Strategic tierSupporting Distribution PartnerTypeChannel Partner/ Reseller/ Distributor
Description

Pars International handles STAT reprints and licensing of stories via its publications page for STAT (parsintl.com/publications/stat), extending reuse of STAT journalism for institutional and commercial reprint customers.

statnews.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight8 records

Each record includes

Type, Description

Peers10 records
1Endpoints News (Endpoints)
TypeDirect peer
Description

Endpoints is a subscription business-news outlet covering biotech R&D, pharma deals, FDA and venture funding with a metered paywall and paid newsletters. It competes directly with STAT for the same life sciences decision-maker audience and subscription budget.

2BioPharma Dive
TypeDirect peer
Description

BioPharma Dive publishes free daily biotech and pharma news with email newsletters and sponsored campaigns, matching STAT's free-to-paid funnel structure in the same regulatory and drug-development beat.

3Fierce Biotech
TypeDirect peer
Description

Fierce Biotech is a vertical publication covering drug development and devices with free articles, newsletters, events and advertising, competing head-to-head with STAT for biotech subscribers and pharma advertising budgets.

4BioWorld
TypeBroad incumbent
Description

BioWorld is an established, subscription-led biotech news and intelligence service that sits inside a larger information-provider group. It is comparable as a paid vertical-news business model with deep industry data products.

5Medscape
TypeBroad incumbent
Description

Medscape combines health news and medical reference content with physician tools and advertising, serving clinicians and industry readers that overlap with STAT's professional audience while operating a broader portfolio.

6Medtech Dive
TypeDirect peer
Description

Medtech Dive covers medical devices, health tech and hospital business with free newsletters and sponsored content — the same device, health-tech and hospital categories that STAT serves as a subscription vertical.

7BioCentury
TypeDirect peer
Description

BioCentury is a paid biotech business-intelligence and news platform delivering analysis, deal data and rankings to biotech investors and executives, closely analogous to STAT+ premium reporting and paid reports.

8Healthcare Dive
TypeDirect peer
Description

Healthcare Dive covers health systems, insurers and health policy for a business audience using free news, newsletters and industry events, overlapping STAT's Policy, Hospitals and Health Insurance coverage areas.

9Muck Rack (Cision)
TypeOthers
Description

Muck Rack is a PR and communications platform that became the first licensed distributor of STAT content. It is a commercial partner and a potential competitor for comms budgets, illustrating how premium journalism is packaged as licensed media assets.

10The Boston Globe
TypeBroad incumbent
Description

The Boston Globe is STAT's parent publication under Boston Globe Media, sharing infrastructure, the group store and the corporate umbrella, and competing for the same general reader advertising market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat8 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration7 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Statnews

Digital Health and Life Sciences Mediastatnews.com

STAT (STAT News) is a Boston-based health, medicine and life sciences news organization founded in 2015, owned by Boston Globe Media. It publishes original reporting and sells a paid STAT+ subscription, proprietary research trackers, paid reports, events and branded content to life sciences professionals, policy stakeholders, institutional buyers and general readers.

What Statnews does

STAT (published as STAT News) is a Boston-based, for-profit health, medicine and life sciences news organization founded in 2015 and operating under the Boston Globe Media umbrella. It produces original reporting, investigations and series across biotech, pharma, health tech, health insurance, hospitals, medical devices, health policy (FDA, NIH), science (CRISPR, gene therapy, neuroscience) and public health. Coverage is produced by specialist correspondents and reporters, including a Washington bureau (HHS and FDA reporters), a Europe correspondent and reporters covering biotech startups and venture capital. STAT sells primarily to three reader groups: life sciences and biopharma business professionals (biotech, pharma, health tech, investors), health policy and government stakeholders, and general readers interested in health and science, plus institutional buyers (hospitals, universities, libraries, life sciences companies). The company states it remains editorially independent and that its financial supporters — including Bloomberg Philanthropies, The Boston Foundation, The Commonwealth Fund, Dana Foundation, Greenwall Foundation, the Knight Science Journalism Program at MIT, NIHCM Foundation, Rise Together and the Robert Wood Johnson Foundation — are not involved in editorial decisions.\n\nThe core product is the STAT+ subscription, a tiered offering that gates in-depth analysis, exclusive reporting, newsletters, premium events, news alerts, podcasts and research reports, delivered on a WordPress-based publishing platform with paywall, account, billing and alert management, a mobile app, a reports storefront, an events platform, and analytics-driven personalization of the subscriber experience. Priced at $39/month, $399/year (advertised as 15% below twelve monthly payments), and a promotional starter tier of $30 for three months before reverting to $399/year, with cancel-anytime terms and discounts for students, educators and health care workers; group subscriptions run $300 per user per year self-serve for 2-10 users with request-a-quote contracts for 11+ users at savings starting at 25%. Four editorially maintained databases form the paid "Tools & Trackers" line: the CRISPR Tracker, the Breakthrough Device Tracker (described as an authoritative database of FDA fast-tracked devices), the Generative AI Tracker and the Obesity Drug Tracker, which covers dozens of weight-loss drugs in development.\n\nRevenue comes from five streams: recurring individual and group STAT+ subscriptions, one-off paid research reports (for example, "Chaotic and politicized: Inside the FDA under Trump" at $49, and the 2025 ranking of biotech's top venture capital firms) through reports.statnews.com, advertising and branded content via the in-house STAT Brand Studio, third-party content licensing (Muck Rack became the first communications platform to license STAT content, announced May 19, 2026) and reprints through Pars International, and a freemium funnel of free newsletters (Morning Rounds, The Readout, Pharmalittle, Pharmalot, D.C. Diagnosis, Readout LOUD, Lab Dish), podcasts (First Opinion, Color Code) and a weekday mini crossword. A dedicated senior vice president for growth & subscriptions and a chief operating officer sit alongside co-founder and executive editor Rick Berke. No revenue, subscriber count, funding history or cap-table data is disclosed in the supplied material.

Statnews firmographics

Firmographics
Name
Statnews
Legal name
STAT
Website
https://statnews.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
251–500 employees
Short description
STAT (STAT News) is a Boston-based health, medicine and life sciences news organization founded in 2015, owned by Boston Globe Media. It publishes original reporting and sells a paid STAT+ subscription, proprietary research trackers, paid reports, events and branded content to life sciences professionals, policy stakeholders, institutional buyers and general readers.
Ownership category
akta.pro rank

Statnews industry classification

Industry
Product category
Digital Health and Life Sciences Media
NAICS
Periodical Publishers (513120), Newspaper, Periodical, Book, and Directory Publishers (5131), Directory and Mailing List Publishers (51314)
SIC
Newspapers: Publishing Or Publishing & Printing (2711)
akta.pro industry
PRIMARYMPAJADAK
Data Journalism & News Intelligence Publishers (Indexes, Election/Market Data)
Media, Entertainment & Sports/Publishing (Books, News, Magazines)/News Publishing (Newspapers, Digital Newsrooms, Wire Services)
SECONDARYMPAJAAAL
Health, Wellness & Fitness Trade Publishing
SECONDARYMPAJAEAD
Health, Fitness & Wellness Magazines
Media, Entertainment & Sports/Publishing (Books, News, Magazines)/Magazine Publishing (Consumer & B2B/Trade Magazines)

Keywords

  • Health and medicine journalism
  • Life sciences news publishing
  • Subscription news content
  • Biotech and pharma reporting
  • Digital media subscription

Where Statnews is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Statnews business model

Business model
GTM type
B2B and B2C
Offering type
Digital Commerce or Content
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. STAT+ individual subscriptions: Paid access to exclusive reporting, analysis, newsletters, premium events and alerts for individual readers; monthly and annual billing with a promotional starter tier and cancel-anytime terms. Annual plan priced at $399 versus $468 for twelve monthly payments (15% saving).
  2. STAT+ group subscriptions: Organization-wide access for teams: self-serve annual seats at $300 per user for 2-10 users and custom-priced contracts for 11+ users with savings starting at 25%, typically sold to hospitals, universities, libraries and life sciences companies.
  3. Paid research reports (STAT Reports): One-off sales of long-form data-and-analysis reports through the reports.statnews.com storefront, e.g. 'Chaotic and politicized: Inside the FDA under Trump' at $49, alongside rankings such as the 2025 edition ranking biotech's top venture capital firms.
  4. Advertising and branded content: Sponsored content and advertising, including a dedicated in-house brand studio (STAT Brand Studio) that creates branded assets for sponsors, supported by an 'Advertise With Us' offering.
  5. Content licensing: Licensing of STAT journalism to third-party communications platforms; Muck Rack became the first communications platform to license STAT content.
  6. Free newsletters and podcasts (acquisition funnel): Free daily and weekly newsletters (Morning Rounds, The Readout, Readout LOUD, Pharmalittle, Pharmalot, D.C. Diagnosis, Lab Dish) and free podcasts that build the audience funnel into paid STAT+ subscriptions rather than direct revenue.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyIndividual monthly STAT+ plan
SubscriptionAnnualStarter promotional annual plan
SubscriptionAnnualIndividual annual STAT+ plan
Per seatAnnualGroup subscription, 2-10 users
Per seatAnnualGroup subscription, 11+ users
Unit PricingOne time/ perpetual licenseIndividual paid research report

Go-to-market motion5 records

Distribution channels7 records

Marketing channels9 records

Statnews product offering

Product offering

Core offering

STAT (STAT News) is a Boston-based news organization founded in 2015 and published by Boston Globe Media that produces journalism about health, medicine and the life sciences, including daily news, investigative series, policy coverage, newsletters, podcasts, video and paid research reports. Its core commercial offering is the "STAT+" paid subscription ($39/month or $399/year for individuals; $300 per user annually for 2-10 user group seats with custom pricing for 11+ users), which unlocks exclusive reporting, in-depth analysis, subscriber-only newsletters, premium events, news alerts and research trackers. Monetization is supplemented by advertising and an in-house branded-content studio (STAT Brand Studio), one-off paid research reports sold through reports.statnews.com (e.g., "Chaotic and politicized: Inside the FDA under Trump" at $49), in-person events such as the annual STAT Summit, and third-party content licensing (e.g., to Muck Rack).

Product overview

STAT News operates a hybrid publishing model: a free, advertising-supported news and analysis platform (news, topics and coverage areas such as Biotech, Pharma, Health Tech, Policy and Science) built around the paid "STAT+" subscription, which bundles premium reporting with a set of modular add-on tools — the STAT Reports line, the "Tools & Trackers" database modules (CRISPR Tracker, Breakthrough Device Tracker, Generative AI Tracker, Obesity Drug Tracker), the newsletter suite (Morning Rounds, The Readout, Pharmalittle, Pharmalot, D.C. Diagnosis, Lab Dish, Color Code), the podcast suite (The Readout LOUD, First Opinion, Color Code, Lab Dish) and premium events such as the STAT Summit — plus engagement products (the STAT Mini crossword, the STAT App, the STAT video channel, Shop STAT), advertising/brand services through STAT Brand Studio, and a content licensing/reprints business operated with Pars International.

Differentiator

Problem solved

Functional benefit

Brands

  • STAT+: STAT's paid subscription offering for in-depth analysis, newsletters, premium events and news alerts, sold as monthly ($39), annual ($399) and group plans.
  • STAT Reports
  • STAT Brand Studio
  • STAT Events
  • STAT Wunderkinds
  • STAT Trackers
  • STAT App
  • Pharmalot / Pharmalittle
  • D.C. Diagnosis
  • The Readout
  • The Readout LOUD
  • Morning Rounds
  • First Opinion
  • Lab Dish
  • Color Code
  • STATus Report

Products and services

  • STAT+ STAT's premium paid subscription tier giving individual readers access to exclusive reporting, in-depth analysis, subscriber newsletters, premium events, news alerts, podcasts and research reports; priced at $39/month or $399/year, with group subscriptions from $300 per user annually, cancel-anytime terms, and discounted plans for students, educators and health care workers.
  • STAT Reports One-off paid research reports blending quantitative data insights with qualitative reporting on pivotal life sciences topics, sold individually through the reports.statnews.com storefront (e.g., 'Chaotic and politicized: Inside the FDA under Trump' at $49).
  • CRISPR Tracker Tool and tracker that follows the latest developments in genome editing, part of STAT's 'Tools & Trackers' line of curated research databases.
  • Breakthrough Device Tracker An authoritative database of the FDA's fast-tracked (breakthrough designation) medical devices, offered under the STAT+ subscription tier.
  • Generative AI Tracker A guide to the health systems and companies driving adoption of generative AI in health care, offered under the STAT+ subscription tier.
  • Obesity Drug Tracker Curated tracker covering the dozens of weight-loss drugs in development, helping readers follow a fast-growing market; part of STAT's Tools & Trackers line.
  • STAT Newsletters Email newsletter portfolio including Morning Rounds (daily), The Readout (biotech), Pharmalittle and Pharmalot (pharma), D.C. Diagnosis (health policy, twice-weekly), Lab Dish, First Opinion and Color Code; free signups with subscriber-only upgrades that feed the STAT+ funnel.
  • STAT Podcasts Podcast suite covering policy to practice, including The Readout LOUD (weekly biotech podcast), First Opinion Podcast (interviews with people and ideas in medicine), Color Code (racial inequities in American health care) and Lab Dish (science and bioethics).
  • STAT Events Portfolio of in-person and virtual events throughout the year, including the annual 2026 STAT Summit in Boston, MA, and virtual recaps such as the AAIC Recap on Alzheimer's; subscriber events feed the STAT+ subscription funnel.
  • STAT Brand Studio In-house brand studio (sbs.statnews.com) providing advertising and branded content opportunities to sponsors, producing custom branded assets for health and science audiences.
  • STAT Content Licensing and Reprints Licensing and reprint service allowing other publications to republish STAT journalism, handled through Pars International; STAT content was also licensed to Muck Rack, the first communications platform to license STAT content (announced May 19, 2026).
  • STAT App Official mobile application providing access to STAT's journalism, newsletters and STAT+ content on mobile.
  • STAT Mini Crossword Weekday mini crossword game on the site that tests readers' knowledge of health and science news and drives habitual daily engagement.
  • STAT Video Video channel publishing status-report explainers (e.g., 'What's next for GLP-1 weight loss drugs?'), conference coverage such as BIO 2026 and interview features.
  • Shop STAT Official STAT-branded merchandise collection fulfilled through the Boston Globe Media online storefront (store.bostonglobe.com).

Companies that use Statnews

Customer profile

Segments5 records

Ideal customer profiles6 records

Statnews technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability4 records

Feature7 records

Statnews partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered strategic licensing deal — first of its kind for stat content and supporting distribution partner.

  • Muck Rackstrategic licensing deal — first of its kind for stat contentOEM/ Whitelabel/ Licensing Partner · 1 May 2026Muck Rack became the first communications platform to license STAT content, extending STAT's journalism into communications/PR tooling and platforms. The announcement positions STAT content as licensable alongside other premium communications content.
  • Pars Internationalsupporting distribution partnerChannel Partner/ Reseller/ DistributorPars International handles STAT reprints and licensing of stories via its publications page for STAT (parsintl.com/publications/stat), extending reuse of STAT journalism for institutional and commercial reprint customers.

Scale indicators5 records

Recent moves6 records

Expansion highlights8 records

Statnews competitors and assessment

Company assessment

Direct peers

  • Endpoints News (Endpoints): Endpoints is a subscription business-news outlet covering biotech R&D, pharma deals, FDA and venture funding with a metered paywall and paid newsletters. It competes directly with STAT for the same life sciences decision-maker audience and subscription budget.
  • BioPharma Dive: BioPharma Dive publishes free daily biotech and pharma news with email newsletters and sponsored campaigns, matching STAT's free-to-paid funnel structure in the same regulatory and drug-development beat.
  • Fierce Biotech: Fierce Biotech is a vertical publication covering drug development and devices with free articles, newsletters, events and advertising, competing head-to-head with STAT for biotech subscribers and pharma advertising budgets.
  • Medtech Dive: Medtech Dive covers medical devices, health tech and hospital business with free newsletters and sponsored content — the same device, health-tech and hospital categories that STAT serves as a subscription vertical.
  • BioCentury: BioCentury is a paid biotech business-intelligence and news platform delivering analysis, deal data and rankings to biotech investors and executives, closely analogous to STAT+ premium reporting and paid reports.
  • Healthcare Dive: Healthcare Dive covers health systems, insurers and health policy for a business audience using free news, newsletters and industry events, overlapping STAT's Policy, Hospitals and Health Insurance coverage areas.

Broad incumbents

  • BioWorld: BioWorld is an established, subscription-led biotech news and intelligence service that sits inside a larger information-provider group. It is comparable as a paid vertical-news business model with deep industry data products.
  • Medscape: Medscape combines health news and medical reference content with physician tools and advertising, serving clinicians and industry readers that overlap with STAT's professional audience while operating a broader portfolio.
  • The Boston Globe: The Boston Globe is STAT's parent publication under Boston Globe Media, sharing infrastructure, the group store and the corporate umbrella, and competing for the same general reader advertising market.

Others

  • Muck Rack (Cision): Muck Rack is a PR and communications platform that became the first licensed distributor of STAT content. It is a commercial partner and a potential competitor for comms budgets, illustrating how premium journalism is packaged as licensed media assets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat8 records

Key risks6 records

Key highlights7 records

Customer concentration

Statnews social profiles

Digital presence

Statnews compliance and trust

Trust signal

Compliance2 records

Statnews financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Statnews leadership team

Management profile

Number of profiles

Profiles9 records

Statnews funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Statnews M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Statnews

What does Statnews do?

STAT (STAT News) is a Boston-based news organization founded in 2015 and published by Boston Globe Media that produces journalism about health, medicine and the life sciences, including daily news, investigative series, policy coverage, newsletters, podcasts, video and paid research reports. Its core commercial offering is the "STAT+" paid subscription ($39/month or $399/year for individuals; $300 per user annually for 2-10 user group seats with custom pricing for 11+ users), which unlocks exclusive reporting, in-depth analysis, subscriber-only newsletters, premium events, news alerts and research trackers. Monetization is supplemented by advertising and an in-house branded-content studio (STAT Brand Studio), one-off paid research reports sold through reports.statnews.com (e.g., "Chaotic and politicized: Inside the FDA under Trump" at $49), in-person events such as the annual STAT Summit, and third-party content licensing (e.g., to Muck Rack).

Is Statnews a public or private company?

Statnews is a private company. It is classified as corporate owned and is currently operating.

When was Statnews founded?

Statnews was founded in 2015. It employs 251 to 500 people.

Where is Statnews based?

Statnews is headquartered in Boston, United States, in the North America region.

How does Statnews make money?

Six revenue lines are on record. STAT+ individual subscriptions are the primary driver. The others are STAT+ group subscriptions, paid research reports (STAT Reports), advertising and branded content, content licensing and free newsletters and podcasts (acquisition funnel).

Who are Statnews's main competitors?

Direct peers on record are Endpoints News (Endpoints), BioPharma Dive, Fierce Biotech, Medtech Dive, BioCentury and Healthcare Dive. Broad incumbents are BioWorld, Medscape and The Boston Globe. Muck Rack (Cision) is listed as an others.

Does Statnews have an API?

No public API is recorded for Statnews.

What industry is Statnews in?

Statnews's product category is Digital Health and Life Sciences Media. Its primary akta.pro industry code is MPAJADAK, Data Journalism & News Intelligence Publishers (Indexes, Election/Market Data), with a secondary code of MPAJAAAL, Health, Wellness & Fitness Trade Publishing. Its NAICS code is 513120 and its SIC code is 2711.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Tech TimesHuidaGene Hid Boy’s Gene Therapy Death for 12 Months: China Trial System FailedShanghai-based HuidaGene Therapeutics concealed the death of a child participant in its CRISPR gene therapy trial for 12 months, revealing the fatality only after an investigation by STAT News. The boy died from acute respiratory distress syndrome triggered by a high-dose AAV vector, and the trial lacked an independent data monitoring committee to oversee safety during dose escalation. This incident highlights significant regulatory gaps in China's investigator-initiated trial system, prompting new state regulations aimed at centralizing oversight.CNBCAmerica's employer-based health insurance system is crumbling: STAT NewsSTAT News reporter Bob Herman appeared on CNBC's 'Squawk Box' to discuss the declining state of America's employer-based health insurance system. The segment highlights concerns regarding the changing landscape and structural challenges facing this specific sector of the U.S. healthcare market. No specific corporate actions or regulatory decisions were detailed in the provided text.SalesTech StarMuck Rack Becomes First Communications Platform to License STAT ContentMuck Rack announced a partnership with STAT, becoming the first communications platform to license STAT's content. The deal surfaces headlines and limited excerpts, with full articles remaining on statnews.com, expanding monitoring across healthcare, biotech, and life sciences.ReutersNewly appointed drugs chief set to leave FDA, STAT News reportsRichard Pazdur, the newly appointed head of the FDA's drug evaluation department, is set to leave the agency weeks after his appointment, according to reports from STAT News. His departure follows a period of significant leadership turnover at the FDA under Health Secretary Robert F. Kennedy Jr., including the ousting of vaccine chief Peter Marks and changes driven by Commissioner Marty Makary. Former FDA Commissioner Robert Califf warned that this attrition leaves the agency with an inexperienced team, describing Pazdur's potential exit as a major loss.BenzingaAnalysts Says Stat News Article Adds Uncertainty To Sarepta's SRP-9001, But Offers Buying Opportunity AroA Stat News report revealed internal FDA debates suggesting a potential rejection of Sarepta Therapeutics' gene therapy SRP-9001, prompting an advisory committee meeting scheduled for May 12. Analysts from William Blair and Mizuho view the resulting market uncertainty as a buying opportunity, maintaining their positive ratings despite the increased regulatory risk.trib.alHealth record company pays hospitals that use its algorithmsEpic, the largest U.S. electronic health record company, pays hospitals to use its algorithms, which can deliver inaccurate predictions. A study found its sepsis algorithm, advertised at 76% accuracy, was correct only 63% of the time. The company's Honor Roll program has awarded hundreds of thousands to nearly $1 million to healthcare systems.trib.alGoogle is making another attempt at personal health recordsGoogle is recruiting about 300 Android users in Northern California, Atlanta, and Chicago to provide feedback on a new consumer-facing medical records tool. This is Google's second attempt, following the shutdown of Google Health in 2012. The company is also developing a doctor-facing Care Studio program.BioSpaceCompanies and Institutions Asked to Publicize Years Worth of Clinical Trial DataFederal officials warned dozens of drug companies and institutions owe over a decade of clinical trial data from 2007-2017, with no set deadline. The pandemic has slowed research, with only 32% of heart failure programs resuming trials as of May 2020. Experts hope guidelines for flexible trial conduct remain after the pandemic.CNBCHere's how options traders are betting Moderna's wild week will endModerna's stock has swung over 20% in a week, with options traders betting on further volatility. Call volume exceeded two times the 20-day average, while institutional traders bought puts over $1 million. The stock traded 8% lower on Thursday.ReutersEarly data on Moderna's COVID-19 vaccine insufficient: Stat NewsData from a small early-stage safety trial of Moderna's COVID-19 vaccine does not provide critical data to assess its effectiveness, according to Stat News. The company's shares fell 10.4% to $71.67 after the news, despite the vaccine producing protective antibodies in a small group of volunteers.